ONDANSETRON

ONDANSETRON was reported 125108 times

ONDANSETRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 277 0.7158
1 SLEEP DISORDER THERAPY 124 0.6263
2 ANTACID THERAPY 74 0.5692
3 ANALGESIC THERAPY 127 0.3956
4 DRUG THERAPY 114 0.3363
5 ANTICOAGULANT THERAPY 76 0.2676
6 NEUROLOGIC NEGLECT SYNDROME 131 0.2356
7 LEFT-TO-RIGHT CARDIAC SHUNT 68 0.2305
8 CAROTID ARTERY THROMBOSIS 140 0.1649
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 139 0.1309
10 TEMPERATURE REGULATION DISORDER 258 0.1157
11 ADJUSTMENT DISORDER 138 0.1062
12 APLASTIC ANAEMIA 535 0.1023
13 NEPHROGENIC ANAEMIA 451 0.0973
14 HYPERPHOSPHATAEMIA 200 0.0929
15 HYPERPARATHYROIDISM SECONDARY 220 0.0877
16 BLOOD PHOSPHORUS INCREASED 235 0.0860
17 ANAESTHETIC COMPLICATION NEUROLOGICAL 68 0.0751
18 FEBRILE NEUTROPENIA 4760 0.0717
19 REBOUND ACID HYPERSECRETION 212 0.0700
20 PLATELET TRANSFUSION 85 0.0660
21 FOETAL DEATH 312 0.0601
22 NEUTROPENIC SEPSIS 426 0.0596
23 NEUTROPENIC COLITIS 122 0.0589
24 TORSADE DE POINTES 449 0.0572
25 OCULOGYRIC CRISIS 113 0.0526
26 PERSONALITY DISORDER 136 0.0519
27 FEBRILE BONE MARROW APLASIA 216 0.0508
28 FOOD ALLERGY 391 0.0506
29 APLASIA 97 0.0495
30 VENTRICULAR FIBRILLATION 550 0.0495
31 SEROTONIN SYNDROME 946 0.0492
32 LONG QT SYNDROME 117 0.0488
33 END STAGE RENAL DISEASE 888 0.0486
34 TOTAL LUNG CAPACITY DECREASED 73 0.0457
35 PSEUDOMONAL SEPSIS 80 0.0456
36 CYTOKINE RELEASE SYNDROME 870 0.0433
37 HEART DISEASE CONGENITAL 152 0.0429
38 CLONUS 117 0.0427
39 HYPOPHOSPHATAEMIA 298 0.0403
40 MUCOSAL INFLAMMATION 1036 0.0395
41 ESCHERICHIA BACTERAEMIA 93 0.0395
42 APPENDICITIS 355 0.0380
43 IRON DEFICIENCY 169 0.0375
44 LUNG OPACITY 97 0.0368
45 VASCULAR DEVICE INFECTION 166 0.0366
46 PLEURITIC PAIN 101 0.0366
47 STRIDOR 106 0.0360
48 LARYNGOSPASM 93 0.0345
49 HOSPICE CARE 339 0.0343
50 CANCER PAIN 87 0.0340
51 BLOOD URIC ACID INCREASED 194 0.0336
52 TRANSFUSION 351 0.0335
53 ATELECTASIS 322 0.0333
54 ELECTROCARDIOGRAM QT PROLONGED 1185 0.0329
55 IMMUNODEFICIENCY 463 0.0310
56 FAILURE TO THRIVE 161 0.0310
57 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 156 0.0308
58 CHRONIC KIDNEY DISEASE 2335 0.0307
59 TYPE I HYPERSENSITIVITY 106 0.0301
60 MYASTHENIA GRAVIS 237 0.0293
61 CLOSTRIDIUM DIFFICILE COLITIS 311 0.0293
62 CARDIOGENIC SHOCK 414 0.0288
63 AORTIC STENOSIS 100 0.0287
64 TROPONIN INCREASED 218 0.0286
65 HYPOMAGNESAEMIA 393 0.0282
66 BLOOD MAGNESIUM DECREASED 238 0.0275
67 GANGRENE 165 0.0274
68 HYPOXIA 959 0.0272
69 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 161 0.0272
70 PSYCHOLOGICAL TRAUMA 231 0.0267
71 VENTRICULAR TACHYCARDIA 437 0.0264
72 PULSELESS ELECTRICAL ACTIVITY 110 0.0263
73 ASCITES 762 0.0259
74 SENSORY LOSS 205 0.0254
75 RHINOVIRUS INFECTION 99 0.0254
76 NON-CARDIAC CHEST PAIN 80 0.0253
77 HYDRONEPHROSIS 189 0.0252
78 HEPATIC CYTOLYSIS 318 0.0249
79 IMPAIRED GASTRIC EMPTYING 339 0.0248
80 ENTEROCOLITIS 143 0.0247
81 TUMOUR LYSIS SYNDROME 215 0.0244
82 SMALL INTESTINAL OBSTRUCTION 299 0.0243
83 CARBOHYDRATE ANTIGEN 125 INCREASED 82 0.0240
84 BACTERAEMIA 285 0.0240
85 PANCREATIC CARCINOMA METASTATIC 68 0.0239
86 PULSE ABSENT 113 0.0237
87 NEUTROPHIL COUNT ABNORMAL 67 0.0237
88 HYPOKALAEMIA 1085 0.0235
89 STAPHYLOCOCCAL BACTERAEMIA 102 0.0234
90 PERIPHERAL SENSORY NEUROPATHY 137 0.0234
91 BACTERIAL INFECTION 432 0.0231
92 PROCTALGIA 147 0.0228
93 ENTERITIS 146 0.0228
94 ACUTE KIDNEY INJURY 3471 0.0227
95 RED CELL DISTRIBUTION WIDTH INCREASED 94 0.0226
96 HAIR COLOUR CHANGES 281 0.0226
97 TASTE DISORDER 457 0.0225
98 HYPONATRAEMIA 1264 0.0224
99 HYPERREFLEXIA 78 0.0224
100 THROMBOCYTOPENIA 2493 0.0223
101 ARTERIAL OCCLUSIVE DISEASE 174 0.0221
102 COELIAC DISEASE 217 0.0221
103 VENOOCCLUSIVE LIVER DISEASE 109 0.0221
104 ARTERIOSPASM CORONARY 88 0.0219
105 SINUS TACHYCARDIA 310 0.0218
106 MULTIPLE ORGAN DYSFUNCTION SYNDROME 614 0.0217
107 ENCEPHALOPATHY 528 0.0215
108 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 82 0.0214
109 ATRIAL SEPTAL DEFECT 179 0.0214
110 INTESTINAL ISCHAEMIA 116 0.0210
111 UPPER RESPIRATORY TRACT INFECTION 968 0.0209
112 LEFT VENTRICULAR DYSFUNCTION 140 0.0209
113 HAIR DISORDER 172 0.0209
114 RENAL TUBULAR NECROSIS 204 0.0208
115 HEMIPLEGIA 172 0.0207
116 PRESCRIBED OVERDOSE 400 0.0207
117 ABDOMINAL TENDERNESS 102 0.0205
118 NEUROPATHY PERIPHERAL 1947 0.0204
119 BURSITIS 247 0.0203
120 HYPERBILIRUBINAEMIA 208 0.0201
121 ACUTE RESPIRATORY FAILURE 385 0.0200
122 MALNUTRITION 223 0.0199
123 PANCYTOPENIA 1105 0.0198
124 RASH MACULO-PAPULAR 439 0.0197
125 BLOOD PHOSPHORUS DECREASED 72 0.0197
126 RENAL INJURY 585 0.0197
127 NEUTROPHIL COUNT DECREASED 802 0.0197
128 BLOOD CREATINE INCREASED 87 0.0196
129 PROTEIN TOTAL DECREASED 74 0.0196
130 TUBULOINTERSTITIAL NEPHRITIS 368 0.0196
131 ELECTROLYTE IMBALANCE 228 0.0196
132 CONSTIPATION 4278 0.0196
133 TOXIC ENCEPHALOPATHY 99 0.0195
134 SEPSIS 2168 0.0194
135 COLITIS 733 0.0193
136 HYPERTRANSAMINASAEMIA 134 0.0192
137 STRESS CARDIOMYOPATHY 112 0.0192
138 ACUTE PULMONARY OEDEMA 107 0.0190
139 VITAMIN B12 DEFICIENCY 77 0.0190
140 HYPOVOLAEMIA 111 0.0190
141 METASTASES TO LYMPH NODES 128 0.0189
142 FULL BLOOD COUNT DECREASED 382 0.0189
143 OESOPHAGITIS 205 0.0187
144 PARONYCHIA 82 0.0186
145 DEHYDRATION 2487 0.0186
146 ANHEDONIA 489 0.0186
147 NEUTROPENIA 2530 0.0186
148 MOTOR DYSFUNCTION 189 0.0185
149 HYPOALBUMINAEMIA 143 0.0184
150 TACHYPNOEA 250 0.0184
151 HYPERNATRAEMIA 91 0.0182
152 RED BLOOD CELL COUNT DECREASED 521 0.0182
153 VENTRICULAR ARRHYTHMIA 66 0.0180
154 UNRESPONSIVE TO STIMULI 464 0.0180
155 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 419 0.0180
156 INFUSION RELATED REACTION 1188 0.0179
157 AFFECT LABILITY 172 0.0179
158 FULL BLOOD COUNT ABNORMAL 189 0.0179
159 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 97 0.0178
160 NEURALGIA 433 0.0178
161 CYTOPENIA 218 0.0178
162 HYPOPHAGIA 452 0.0177
163 STOMATITIS 1070 0.0176
164 BENIGN PROSTATIC HYPERPLASIA 91 0.0176
165 APNOEA 137 0.0176
166 CLOSTRIDIUM DIFFICILE INFECTION 384 0.0176
167 PLEURAL EFFUSION 1068 0.0175
168 MUSCLE SPASTICITY 215 0.0175
169 PLASMA CELL MYELOMA 682 0.0175
170 ORAL CANDIDIASIS 230 0.0174
171 ORAL PAIN 390 0.0174
172 FLANK PAIN 163 0.0174
173 MYOCLONUS 207 0.0173
174 SEPTIC SHOCK 754 0.0173
175 PRODUCT ADMINISTRATION INTERRUPTED 136 0.0173
176 BLOOD LACTIC ACID INCREASED 91 0.0173
177 BREATH SOUNDS ABNORMAL 85 0.0172
178 BLOOD ALBUMIN DECREASED 136 0.0171
179 PATENT DUCTUS ARTERIOSUS 68 0.0171
180 IMPAIRED QUALITY OF LIFE 246 0.0171
181 MENTAL STATUS CHANGES 474 0.0171
182 UROSEPSIS 156 0.0169
183 ILEUS 210 0.0169
184 HAIR TEXTURE ABNORMAL 226 0.0169
185 TUMOUR MARKER INCREASED 81 0.0169
186 LEFT VENTRICULAR HYPERTROPHY 72 0.0168
187 VOMITING 7884 0.0168
188 ANAPHYLACTOID REACTION 69 0.0168
189 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 159 0.0166
190 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 129 0.0166
191 DEVICE RELATED INFECTION 255 0.0165
192 MADAROSIS 192 0.0165
193 NEUROTOXICITY 288 0.0164
194 CYTOMEGALOVIRUS VIRAEMIA 73 0.0164
195 SINUS CONGESTION 221 0.0163
196 GASTROINTESTINAL MOTILITY DISORDER 87 0.0162
197 EATING DISORDER 346 0.0162
198 INFUSION SITE PAIN 209 0.0162
199 RENAL FAILURE 2149 0.0162
200 ODYNOPHAGIA 96 0.0161
201 WHITE BLOOD CELL COUNT DECREASED 1741 0.0160
202 BODY TEMPERATURE INCREASED 327 0.0160
203 CONGENITAL ANOMALY 124 0.0160
204 EMBOLISM 133 0.0160
205 CANDIDA INFECTION 270 0.0160
206 TRICUSPID VALVE INCOMPETENCE 127 0.0160
207 NAUSEA 12637 0.0160
208 WEIGHT FLUCTUATION 167 0.0159
209 BLOOD ALKALINE PHOSPHATASE INCREASED 396 0.0159
210 ANAPHYLACTIC REACTION 880 0.0159
211 INFUSION SITE ERYTHEMA 134 0.0159
212 VENTRICULAR SEPTAL DEFECT 91 0.0159
213 INFUSION SITE SWELLING 100 0.0159
214 DECREASED APPETITE 3679 0.0158
215 PLATELET COUNT DECREASED 1685 0.0158
216 HYPERVOLAEMIA 78 0.0158
217 SUPRAVENTRICULAR TACHYCARDIA 151 0.0158
218 HEMIPARESIS 267 0.0157
219 LEUKOPENIA 788 0.0157
220 BLOOD POTASSIUM DECREASED 473 0.0157
221 LYMPHOCYTE COUNT DECREASED 277 0.0157
222 TACHYCARDIA 1389 0.0156
223 CARDIAC MURMUR 135 0.0156
224 ESCHERICHIA URINARY TRACT INFECTION 66 0.0155
225 BLOOD CALCIUM INCREASED 136 0.0155
226 TOXIC EPIDERMAL NECROLYSIS 235 0.0155
227 URINE OUTPUT DECREASED 135 0.0154
228 DISEASE PROGRESSION 1822 0.0154
229 RESPIRATORY SYNCYTIAL VIRUS INFECTION 134 0.0154
230 APPETITE DISORDER 102 0.0154
231 HAEMORRHOIDS 299 0.0153
232 BRONCHOSPASM 218 0.0153
233 ABSCESS LIMB 65 0.0152
234 HYPERLIPIDAEMIA 182 0.0152
235 LYMPHOPENIA 215 0.0152
236 STAPHYLOCOCCAL SEPSIS 75 0.0152
237 CARDIAC ARREST 1251 0.0151
238 PNEUMOTHORAX 240 0.0151
239 RETCHING 322 0.0151
240 ANAEMIA 2879 0.0151
241 OXYGEN SATURATION DECREASED 847 0.0151
242 HYPERCALCAEMIA 186 0.0150
243 KLEBSIELLA INFECTION 76 0.0150
244 ANAL INCONTINENCE 135 0.0150
245 LARGE INTESTINE PERFORATION 104 0.0150
246 METASTASES TO LIVER 262 0.0149
247 ASPIRATION 163 0.0149
248 BLOOD BILIRUBIN INCREASED 401 0.0148
249 RHINITIS ALLERGIC 66 0.0148
250 CHOLECYSTITIS 176 0.0148
251 PYREXIA 5100 0.0147
252 ABDOMINAL PAIN 3411 0.0146
253 EXPOSURE DURING PREGNANCY 911 0.0146
254 DERMATITIS ACNEIFORM 89 0.0146
255 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 150 0.0146
256 ULCER 232 0.0146
257 APHASIA 440 0.0146
258 SINUS BRADYCARDIA 140 0.0145
259 BLOOD CALCIUM DECREASED 162 0.0144
260 LUNG INFILTRATION 127 0.0144
261 COORDINATION ABNORMAL 200 0.0143
262 DYSTONIA 278 0.0143
263 TRISMUS 74 0.0143
264 HAEMATOCRIT DECREASED 284 0.0143
265 ANAL ABSCESS 77 0.0143
266 EJECTION FRACTION DECREASED 222 0.0143
267 PANCREATITIS ACUTE 321 0.0143
268 RESPIRATORY DISTRESS 394 0.0143
269 METASTASES TO CENTRAL NERVOUS SYSTEM 184 0.0143
270 FAECALOMA 78 0.0142
271 ANAPHYLACTIC SHOCK 367 0.0142
272 COLITIS ISCHAEMIC 96 0.0142
273 PATHOLOGICAL FRACTURE 72 0.0142
274 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 243 0.0142
275 FOETAL GROWTH RESTRICTION 86 0.0141
276 HAEMORRHOIDAL HAEMORRHAGE 69 0.0141
277 BLOOD CREATININE INCREASED 920 0.0141
278 ORTHOSTATIC HYPOTENSION 245 0.0141
279 BRAIN FOG 220 0.0140
280 HICCUPS 115 0.0140
281 BLOOD SODIUM DECREASED 262 0.0139
282 ACUTE MYELOID LEUKAEMIA 216 0.0138
283 OROPHARYNGEAL DISCOMFORT 125 0.0138
284 ATRIAL FLUTTER 110 0.0138
285 MOUTH ULCERATION 288 0.0137
286 INTESTINAL PERFORATION 153 0.0136
287 RESPIRATORY TRACT CONGESTION 216 0.0136
288 LEUKOCYTOSIS 246 0.0136
289 PNEUMONITIS 369 0.0135
290 PRE-EXISTING CONDITION IMPROVED 84 0.0134
291 ENTEROCOCCAL INFECTION 65 0.0134
292 ECONOMIC PROBLEM 203 0.0134
293 LIPASE INCREASED 102 0.0133
294 GOUT 238 0.0133
295 FLUID OVERLOAD 193 0.0132
296 DIARRHOEA 8550 0.0132
297 COVID-19 PNEUMONIA 156 0.0132
298 OSTEOPENIA 200 0.0132
299 BLOOD TEST ABNORMAL 185 0.0132
300 ALANINE AMINOTRANSFERASE INCREASED 808 0.0131
301 NEPHROLITHIASIS 603 0.0131
302 ESCHERICHIA INFECTION 108 0.0131
303 SKIN TOXICITY 74 0.0131
304 INTESTINAL OBSTRUCTION 493 0.0131
305 HYPOCALCAEMIA 247 0.0130
306 ASPARTATE AMINOTRANSFERASE INCREASED 692 0.0130
307 RASH ERYTHEMATOUS 621 0.0130
308 BRAIN OEDEMA 164 0.0130
309 HYPOTENSION 2600 0.0129
310 ORAL DISORDER 95 0.0129
311 CONTRAINDICATED PRODUCT ADMINISTERED 392 0.0129
312 HAEMATEMESIS 328 0.0129
313 HAEMOGLOBIN ABNORMAL 83 0.0129
314 HYPERTHERMIA 98 0.0128
315 HAEMOGLOBIN DECREASED 1314 0.0128
316 CYANOSIS 201 0.0128
317 UPPER GASTROINTESTINAL HAEMORRHAGE 215 0.0128
318 CELLULITIS 644 0.0128
319 DECUBITUS ULCER 104 0.0127
320 PLATELET COUNT ABNORMAL 77 0.0127
321 ACIDOSIS 97 0.0127
322 NEOPLASM PROGRESSION 439 0.0126
323 BONE MARROW FAILURE 256 0.0126
324 CHOLECYSTITIS CHRONIC 84 0.0125
325 FEEDING DISORDER 254 0.0125
326 SINUS DISORDER 248 0.0125
327 CARDIOMEGALY 154 0.0125
328 VITAMIN D DEFICIENCY 122 0.0125
329 PULMONARY EMBOLISM 1186 0.0125
330 SKIN HAEMORRHAGE 184 0.0124
331 GASTROENTERITIS 181 0.0124
332 DYSARTHRIA 466 0.0124
333 POLYNEUROPATHY 148 0.0123
334 CARDIO-RESPIRATORY ARREST 516 0.0123
335 VENTRICULAR EXTRASYSTOLES 128 0.0123
336 IRON DEFICIENCY ANAEMIA 113 0.0122
337 MUSCULOSKELETAL CHEST PAIN 189 0.0122
338 PERIORBITAL SWELLING 69 0.0122
339 DIARRHOEA HAEMORRHAGIC 114 0.0122
340 CYSTITIS 388 0.0122
341 SEDATION 319 0.0122
342 GENERAL PHYSICAL HEALTH DETERIORATION 1403 0.0121
343 FLUID RETENTION 616 0.0121
344 PERICARDIAL EFFUSION 280 0.0121
345 POOR VENOUS ACCESS 125 0.0121
346 ACUTE CORONARY SYNDROME 100 0.0121
347 MALIGNANT NEOPLASM PROGRESSION 1233 0.0120
348 RESPIRATORY FAILURE 878 0.0120
349 LIVER FUNCTION TEST INCREASED 258 0.0120
350 PULMONARY MASS 179 0.0120
351 DYSPNOEA EXERTIONAL 452 0.0120
352 URINARY TRACT INFECTION 2046 0.0120
353 PETECHIAE 125 0.0120
354 HYPERHIDROSIS 1537 0.0119
355 FATIGUE 9268 0.0119
356 NEPHROPATHY 111 0.0119
357 CARDIOTOXICITY 106 0.0119
358 PREMATURE DELIVERY 189 0.0119
359 NEPHROPATHY TOXIC 133 0.0118
360 EPISTAXIS 881 0.0118
361 MATERNAL EXPOSURE DURING PREGNANCY 1049 0.0118
362 CHILLS 1379 0.0118
363 DYSPHAGIA 1103 0.0116
364 HEPATOMEGALY 114 0.0116
365 AGRANULOCYTOSIS 215 0.0116
366 GASTRITIS 304 0.0115
367 FACIAL PAIN 103 0.0115
368 NEUTROPHIL COUNT INCREASED 118 0.0115
369 RESPIRATORY DEPRESSION 141 0.0115
370 PNEUMONIA 3724 0.0115
371 SKIN INFECTION 129 0.0115
372 HEPATOCELLULAR INJURY 163 0.0115
373 ACUTE RESPIRATORY DISTRESS SYNDROME 203 0.0115
374 CHOLECYSTITIS ACUTE 65 0.0115
375 DERMATITIS BULLOUS 83 0.0115
376 HYPOTHERMIA 116 0.0114
377 TOXIC SKIN ERUPTION 115 0.0114
378 ADRENAL INSUFFICIENCY 138 0.0114
379 GASTROENTERITIS VIRAL 205 0.0113
380 HYPERTONIA 65 0.0113
381 TRANSAMINASES INCREASED 252 0.0113
382 LOW BIRTH WEIGHT BABY 90 0.0113
383 RESPIRATION ABNORMAL 78 0.0113
384 BLOOD COUNT ABNORMAL 171 0.0113
385 ABDOMINAL DISTENSION 1177 0.0113
386 RIGHT VENTRICULAR FAILURE 79 0.0113
387 C-REACTIVE PROTEIN INCREASED 409 0.0112
388 METASTASES TO BONE 184 0.0112
389 POST-TRAUMATIC STRESS DISORDER 75 0.0112
390 GASTROOESOPHAGEAL REFLUX DISEASE 899 0.0112
391 CHOLANGITIS 69 0.0111
392 CARDIOMYOPATHY 164 0.0111
393 DRUG INTERACTION 1748 0.0110
394 GENERALISED TONIC-CLONIC SEIZURE 182 0.0110
395 PHARYNGITIS 136 0.0110
396 ELECTROCARDIOGRAM ABNORMAL 86 0.0109
397 EXTRASYSTOLES 76 0.0109
398 HAEMOPTYSIS 303 0.0109
399 GRAFT VERSUS HOST DISEASE 78 0.0108
400 METASTASIS 77 0.0108
401 INFUSION SITE EXTRAVASATION 67 0.0108
402 GENERALISED OEDEMA 133 0.0107
403 HEPATIC ENZYME INCREASED 730 0.0107
404 BRONCHOPULMONARY ASPERGILLOSIS 83 0.0107
405 ANURIA 92 0.0107
406 ASTHENIA 4012 0.0107
407 BACK PAIN 2478 0.0107
408 PYELONEPHRITIS 92 0.0106
409 PULMONARY OEDEMA 475 0.0106
410 HAEMOLYTIC ANAEMIA 95 0.0106
411 DECREASED IMMUNE RESPONSIVENESS 104 0.0106
412 PLATELET COUNT INCREASED 138 0.0106
413 SECOND PRIMARY MALIGNANCY 88 0.0106
414 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 79 0.0105
415 MITRAL VALVE INCOMPETENCE 118 0.0104
416 BRADYCARDIA 552 0.0104
417 HEPATIC ENCEPHALOPATHY 97 0.0104
418 GASTROINTESTINAL DISORDER 931 0.0104
419 RESPIRATORY TRACT INFECTION 269 0.0103
420 SEASONAL ALLERGY 146 0.0103
421 HERPES SIMPLEX 67 0.0103
422 HEPATOTOXICITY 229 0.0103
423 PRODUCT DOSE OMISSION IN ERROR 291 0.0103
424 PULMONARY HYPERTENSION 214 0.0103
425 BLOOD UREA INCREASED 172 0.0103
426 WEIGHT DECREASED 2860 0.0102
427 CIRCULATORY COLLAPSE 174 0.0102
428 METASTASES TO LUNG 118 0.0102
429 TOOTH ABSCESS 104 0.0102
430 MUSCLE RIGIDITY 122 0.0102
431 GAMMA-GLUTAMYLTRANSFERASE INCREASED 226 0.0102
432 ATAXIA 121 0.0102
433 ONYCHOCLASIS 70 0.0102
434 MICTURITION URGENCY 116 0.0101
435 PNEUMONIA BACTERIAL 93 0.0101
436 FOETAL EXPOSURE DURING PREGNANCY 822 0.0101
437 PREMATURE BABY 304 0.0101
438 HYPERTENSION 2136 0.0101
439 CONCUSSION 78 0.0101
440 ATRIAL FIBRILLATION 981 0.0101
441 BOWEL MOVEMENT IRREGULARITY 77 0.0100
442 LUNG INFECTION 156 0.0100
443 BLOOD LACTATE DEHYDROGENASE INCREASED 159 0.0100
444 PSEUDOMONAS INFECTION 86 0.0100
445 SNEEZING 224 0.0100
446 HAEMATURIA 341 0.0099
447 DEEP VEIN THROMBOSIS 647 0.0099
448 SKIN LACERATION 108 0.0099
449 BONE PAIN 581 0.0099
450 SLEEP APNOEA SYNDROME 189 0.0099
451 SPINAL PAIN 116 0.0099
452 LOWER GASTROINTESTINAL HAEMORRHAGE 73 0.0099
453 URINARY RETENTION 329 0.0099
454 METABOLIC ACIDOSIS 314 0.0098
455 LIVE BIRTH 82 0.0098
456 DYSPHONIA 573 0.0098
457 SPINAL OSTEOARTHRITIS 86 0.0098
458 PALLOR 266 0.0098
459 FAECES SOFT 71 0.0098
460 PRODUCTIVE COUGH 466 0.0098
461 THROMBOSIS 784 0.0097
462 PULMONARY THROMBOSIS 106 0.0097
463 DRUG INTOLERANCE 939 0.0097
464 LOWER RESPIRATORY TRACT INFECTION 441 0.0097
465 INFECTION 1403 0.0097
466 PNEUMONIA ASPIRATION 242 0.0097
467 RHINITIS 78 0.0097
468 HYPERKALAEMIA 339 0.0097
469 INCONTINENCE 102 0.0096
470 BRONCHIECTASIS 65 0.0096
471 NEUROLEPTIC MALIGNANT SYNDROME 114 0.0096
472 CHEST DISCOMFORT 984 0.0096
473 DRY MOUTH 779 0.0096
474 HEREDITARY ANGIOEDEMA 103 0.0096
475 RIB FRACTURE 197 0.0096
476 HIATUS HERNIA 124 0.0096
477 PNEUMOCYSTIS JIROVECII PNEUMONIA 96 0.0096
478 CONFUSIONAL STATE 1545 0.0096
479 MYELODYSPLASTIC SYNDROME 138 0.0095
480 QUALITY OF LIFE DECREASED 128 0.0095
481 EAR PAIN 185 0.0095
482 MYDRIASIS 122 0.0095
483 BLOOD PRESSURE ABNORMAL 189 0.0095
484 HYPERGLYCAEMIA 346 0.0095
485 NEOPLASM 109 0.0095
486 EAR INFECTION 252 0.0095
487 HAEMODYNAMIC INSTABILITY 72 0.0094
488 DIVERTICULITIS 261 0.0094
489 LABORATORY TEST ABNORMAL 277 0.0094
490 FACIAL PARALYSIS 80 0.0094
491 AGEUSIA 234 0.0094
492 PRODUCT DISTRIBUTION ISSUE 87 0.0094
493 NIGHT SWEATS 302 0.0094
494 ABDOMINAL PAIN LOWER 237 0.0094
495 BLOOD IRON DECREASED 111 0.0093
496 ANGINA PECTORIS 267 0.0093
497 CHEST PAIN 1714 0.0092
498 CHOLELITHIASIS 303 0.0092
499 THERAPY INTERRUPTED 659 0.0092
500 FLUSHING 937 0.0092
501 RENAL CYST 73 0.0092
502 GASTROINTESTINAL INFECTION 82 0.0091
503 RESPIRATORY RATE INCREASED 81 0.0091
504 KIDNEY INFECTION 179 0.0091
505 BLOOD PRESSURE INCREASED 1393 0.0091
506 DYSPNOEA 5149 0.0091
507 GASTROINTESTINAL PAIN 100 0.0091
508 DECREASED ACTIVITY 98 0.0091
509 DIZZINESS POSTURAL 88 0.0091
510 SUDDEN DEATH 96 0.0091
511 FACE OEDEMA 153 0.0091
512 WHITE BLOOD CELL COUNT INCREASED 348 0.0091
513 DELIRIUM 314 0.0090
514 PANCREATITIS 478 0.0090
515 PURPURA 80 0.0090
516 PHOTOPHOBIA 170 0.0090
517 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 471 0.0090
518 POST PROCEDURAL COMPLICATION 173 0.0090
519 COUGH 2526 0.0090
520 SHOCK HAEMORRHAGIC 73 0.0090
521 GALLBLADDER DISORDER 160 0.0090
522 DERMATITIS CONTACT 102 0.0089
523 GINGIVAL BLEEDING 122 0.0089
524 EMPHYSEMA 90 0.0089
525 SPUTUM DISCOLOURED 84 0.0088
526 DIFFUSE LARGE B-CELL LYMPHOMA 68 0.0088
527 RHINORRHOEA 569 0.0088
528 SINUSITIS 902 0.0088
529 OROPHARYNGEAL PAIN 814 0.0088
530 PAIN IN JAW 249 0.0088
531 MUSCULAR WEAKNESS 998 0.0088
532 DYSURIA 323 0.0088
533 VITAMIN D DECREASED 75 0.0088
534 HEPATIC FAILURE 264 0.0087
535 PARAESTHESIA ORAL 126 0.0087
536 IMMUNOSUPPRESSION 77 0.0087
537 PRESYNCOPE 212 0.0087
538 SPLENOMEGALY 102 0.0087
539 COAGULOPATHY 145 0.0087
540 SEIZURE 1005 0.0087
541 LIVER FUNCTION TEST ABNORMAL 253 0.0087
542 DYSPEPSIA 855 0.0087
543 LETHARGY 499 0.0087
544 DISSEMINATED INTRAVASCULAR COAGULATION 122 0.0087
545 HYPERSOMNIA 248 0.0086
546 CHOLESTASIS 166 0.0086
547 ALOPECIA 1687 0.0086
548 NECK PAIN 480 0.0086
549 DENTAL CARIES 95 0.0086
550 SPINAL COMPRESSION FRACTURE 71 0.0086
551 PHARYNGEAL SWELLING 84 0.0086
552 ANXIETY 2440 0.0086
553 OEDEMA PERIPHERAL 1044 0.0086
554 PULMONARY ARTERIAL HYPERTENSION 124 0.0085
555 JAUNDICE 230 0.0085
556 SYNCOPE 854 0.0085
557 DEPRESSED LEVEL OF CONSCIOUSNESS 337 0.0085
558 ABDOMINAL PAIN UPPER 1751 0.0085
559 AKATHISIA 116 0.0085
560 HEART RATE INCREASED 838 0.0084
561 PERIPHERAL COLDNESS 116 0.0084
562 FUNGAL INFECTION 281 0.0084
563 BLOOD PRESSURE DECREASED 558 0.0084
564 NIGHTMARE 290 0.0084
565 ILLNESS 863 0.0084
566 CONJUNCTIVITIS 155 0.0083
567 HYPERSENSITIVITY 1549 0.0083
568 NAIL DISORDER 73 0.0083
569 THROAT TIGHTNESS 225 0.0083
570 GROIN PAIN 73 0.0083
571 INSURANCE ISSUE 127 0.0083
572 GASTRIC ULCER 157 0.0083
573 TENDERNESS 86 0.0082
574 SLEEP DISORDER 582 0.0082
575 TEMPERATURE INTOLERANCE 85 0.0082
576 VIRAL INFECTION 274 0.0082
577 ERYTHEMA 1689 0.0082
578 STAPHYLOCOCCAL INFECTION 271 0.0082
579 OFF LABEL USE 7185 0.0082
580 TOOTH INFECTION 108 0.0082
581 POLYURIA 67 0.0082
582 BLADDER DISORDER 81 0.0081
583 ABSCESS 130 0.0081
584 INJURY 572 0.0081
585 LYMPHADENOPATHY 288 0.0081
586 SKIN FISSURES 159 0.0081
587 BLOOD POTASSIUM INCREASED 132 0.0081
588 BLOOD PRESSURE SYSTOLIC INCREASED 158 0.0081
589 FEELING HOT 496 0.0081
590 LIGAMENT SPRAIN 80 0.0081
591 OEDEMA 438 0.0081
592 INFLUENZA 899 0.0081
593 RASH 3510 0.0080
594 ACUTE HEPATIC FAILURE 110 0.0080
595 RESTLESS LEGS SYNDROME 146 0.0080
596 BODY TEMPERATURE DECREASED 79 0.0080
597 UPPER-AIRWAY COUGH SYNDROME 66 0.0080
598 MUSCLE STRAIN 69 0.0080
599 PERIPHERAL SWELLING 1225 0.0079
600 SPINAL FRACTURE 159 0.0079
601 HEAD INJURY 251 0.0079
602 FLATULENCE 449 0.0079
603 PULMONARY CONGESTION 104 0.0079
604 MIGRAINE 752 0.0079
605 RESTLESSNESS 288 0.0079
606 PROTEINURIA 149 0.0078
607 EMOTIONAL DISTRESS 948 0.0078
608 HEPATITIS 200 0.0078
609 SKIN ULCER 202 0.0078
610 DYSGEUSIA 580 0.0078
611 HYPERTHYROIDISM 113 0.0078
612 THROMBOTIC MICROANGIOPATHY 76 0.0078
613 EYE INFECTION 88 0.0078
614 TOOTHACHE 141 0.0078
615 INTERVERTEBRAL DISC DEGENERATION 72 0.0078
616 WOUND INFECTION 85 0.0078
617 DEVELOPMENTAL DELAY 70 0.0078
618 RENAL IMPAIRMENT 651 0.0077
619 LIMB INJURY 210 0.0077
620 OBSTRUCTIVE AIRWAYS DISORDER 86 0.0077
621 MUSCLE TWITCHING 178 0.0077
622 PAIN 4725 0.0077
623 LOCALISED INFECTION 186 0.0077
624 RECTAL HAEMORRHAGE 330 0.0077
625 MYOCARDITIS 88 0.0077
626 HEPATIC STEATOSIS 143 0.0077
627 INTENTIONAL PRODUCT MISUSE 672 0.0077
628 URINARY INCONTINENCE 227 0.0077
629 NOCTURIA 93 0.0077
630 COLD SWEAT 135 0.0077
631 HYPOTHYROIDISM 244 0.0076
632 PRODUCT USE IN UNAPPROVED INDICATION 1882 0.0076
633 HOT FLUSH 572 0.0076
634 GLOMERULAR FILTRATION RATE DECREASED 93 0.0076
635 MUSCLE SPASMS 1388 0.0076
636 HAEMORRHAGE INTRACRANIAL 113 0.0075
637 JOINT INJURY 161 0.0075
638 SHOCK 173 0.0075
639 RASH PRURITIC 406 0.0075
640 PHARYNGITIS STREPTOCOCCAL 81 0.0075
641 EOSINOPHILIA 131 0.0075
642 ASTHMA 843 0.0075
643 APHONIA 104 0.0074
644 THIRST 133 0.0074
645 BLOOD PRESSURE FLUCTUATION 178 0.0074
646 MULTI-ORGAN FAILURE 128 0.0074
647 INTENTIONAL DOSE OMISSION 211 0.0074
648 FEELING COLD 206 0.0074
649 PARAESTHESIA 1164 0.0074
650 SOMNOLENCE 1489 0.0074
651 OSTEOPOROSIS 304 0.0074
652 TREMOR 1225 0.0074
653 RENAL PAIN 78 0.0074
654 LOSS OF CONSCIOUSNESS 940 0.0073
655 ABDOMINAL DISCOMFORT 1230 0.0073
656 HEADACHE 4593 0.0073
657 SALIVARY HYPERSECRETION 73 0.0073
658 DISCOMFORT 445 0.0073
659 ACCIDENT 87 0.0073
660 RENAL FAILURE ACUTE 309 0.0073
661 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
662 HYPERTENSIVE CRISIS 81 0.0073
663 SARS-COV-2 TEST POSITIVE 96 0.0073
664 DYSKINESIA 294 0.0072
665 COVID-19 1269 0.0072
666 THERAPY CESSATION 371 0.0072
667 MASS 101 0.0072
668 BLISTER 405 0.0072
669 PARKINSONISM 70 0.0072
670 ACUTE MYOCARDIAL INFARCTION 210 0.0071
671 FOOT FRACTURE 135 0.0071
672 FAECES DISCOLOURED 154 0.0071
673 ERUCTATION 137 0.0071
674 SWELLING 661 0.0071
675 ORAL DISCOMFORT 98 0.0070
676 NODULE 92 0.0070
677 RESPIRATORY ARREST 193 0.0070
678 CONTUSION 673 0.0070
679 DISORIENTATION 277 0.0070
680 THERAPY PARTIAL RESPONDER 109 0.0070
681 FALL 2321 0.0070
682 PROSTATIC SPECIFIC ANTIGEN INCREASED 96 0.0070
683 ORAL HERPES 136 0.0070
684 RASH MACULAR 243 0.0069
685 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 118 0.0069
686 BRONCHITIS 514 0.0069
687 PRODUCT TASTE ABNORMAL 94 0.0069
688 HYPERCHOLESTEROLAEMIA 67 0.0069
689 MALAISE 3041 0.0069
690 CARDIAC FAILURE 556 0.0069
691 SPEECH DISORDER 362 0.0069
692 SPINAL OPERATION 85 0.0069
693 JOINT SWELLING 832 0.0069
694 NASAL CONGESTION 402 0.0068
695 TRANSIENT ISCHAEMIC ATTACK 230 0.0068
696 AGITATION 500 0.0068
697 THERAPY NON-RESPONDER 306 0.0068
698 LUNG DISORDER 333 0.0068
699 BRAIN INJURY 68 0.0068
700 HAEMATOCHEZIA 374 0.0068
701 SUBDURAL HAEMATOMA 97 0.0068
702 SKIN EXFOLIATION 571 0.0068
703 DIALYSIS 96 0.0068
704 FISTULA 76 0.0068
705 LACRIMATION INCREASED 204 0.0067
706 PERITONITIS 139 0.0067
707 SKIN LESION 184 0.0067
708 BREAST CANCER METASTATIC 72 0.0067
709 BLOOD URINE PRESENT 127 0.0067
710 VERTIGO 407 0.0067
711 PALPITATIONS 782 0.0067
712 SWELLING FACE 433 0.0066
713 CATARACT 396 0.0066
714 RASH PAPULAR 149 0.0066
715 DRUG LEVEL INCREASED 110 0.0066
716 INTENTIONAL PRODUCT USE ISSUE 582 0.0066
717 HYPOAESTHESIA 994 0.0066
718 LIP SWELLING 221 0.0066
719 POST PROCEDURAL HAEMORRHAGE 77 0.0066
720 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 317 0.0066
721 RENAL DISORDER 307 0.0066
722 INITIAL INSOMNIA 67 0.0065
723 DIPLOPIA 169 0.0065
724 PRODUCT USE ISSUE 1219 0.0065
725 NERVE INJURY 72 0.0065
726 GASTRIC DISORDER 222 0.0065
727 SCIATICA 103 0.0065
728 DIZZINESS 3218 0.0064
729 COLON CANCER 96 0.0064
730 TOOTH FRACTURE 71 0.0064
731 HEART RATE DECREASED 226 0.0064
732 RESPIRATORY DISORDER 192 0.0064
733 DEPRESSION 1460 0.0064
734 MYOCARDIAL ISCHAEMIA 73 0.0064
735 HOSPITALISATION 985 0.0064
736 OSTEOMYELITIS 116 0.0064
737 FREQUENT BOWEL MOVEMENTS 173 0.0064
738 WHEEZING 379 0.0064
739 BALANCE DISORDER 552 0.0064
740 SKIN DISORDER 213 0.0064
741 ANGIOEDEMA 282 0.0064
742 HIP FRACTURE 205 0.0064
743 HEART RATE IRREGULAR 144 0.0064
744 HALLUCINATION 480 0.0064
745 OSTEOARTHRITIS 270 0.0064
746 DRUG-INDUCED LIVER INJURY 199 0.0063
747 CHROMATURIA 143 0.0063
748 CYTOMEGALOVIRUS INFECTION 105 0.0063
749 PRODUCT DOSE OMISSION ISSUE 1838 0.0062
750 INFLUENZA LIKE ILLNESS 513 0.0062
751 TOOTH DISORDER 138 0.0062
752 ANKLE FRACTURE 96 0.0062
753 GASTROINTESTINAL HAEMORRHAGE 518 0.0062
754 PHOTOSENSITIVITY REACTION 102 0.0062
755 LIMB DISCOMFORT 191 0.0062
756 IRRITABLE BOWEL SYNDROME 132 0.0062
757 POOR QUALITY SLEEP 132 0.0061
758 PERICARDITIS 103 0.0061
759 INTERVERTEBRAL DISC PROTRUSION 134 0.0061
760 INTERNATIONAL NORMALISED RATIO INCREASED 174 0.0061
761 GLOSSODYNIA 136 0.0061
762 COMPLICATION ASSOCIATED WITH DEVICE 88 0.0061
763 SKIN DISCOLOURATION 278 0.0060
764 HEAD DISCOMFORT 107 0.0060
765 DEATH 5204 0.0060
766 CHOLECYSTECTOMY 69 0.0060
767 CEREBRAL HAEMORRHAGE 216 0.0060
768 THYROID DISORDER 93 0.0060
769 PARALYSIS 86 0.0060
770 PAIN IN EXTREMITY 1764 0.0060
771 POLLAKIURIA 249 0.0060
772 SKIN REACTION 84 0.0060
773 HEPATIC CIRRHOSIS 112 0.0060
774 GAIT INABILITY 199 0.0059
775 HERPES ZOSTER 342 0.0059
776 WOUND 166 0.0059
777 STEVENS-JOHNSON SYNDROME 132 0.0059
778 ARRHYTHMIA 281 0.0059
779 MUSCULOSKELETAL DISCOMFORT 102 0.0059
780 TOXICITY TO VARIOUS AGENTS 998 0.0059
781 LIVER DISORDER 262 0.0059
782 CONDITION AGGRAVATED 1796 0.0059
783 DRY SKIN 787 0.0059
784 RHEUMATOID ARTHRITIS 669 0.0059
785 GAIT DISTURBANCE 1117 0.0058
786 MELAENA 128 0.0058
787 CYST 72 0.0058
788 CARPAL TUNNEL SYNDROME 81 0.0058
789 SURGERY 339 0.0058
790 INTERNAL HAEMORRHAGE 66 0.0058
791 MYALGIA 979 0.0058
792 WRIST FRACTURE 69 0.0058
793 BLOOD CHOLESTEROL INCREASED 268 0.0057
794 NASOPHARYNGITIS 1059 0.0057
795 SCAR 98 0.0057
796 COGNITIVE DISORDER 267 0.0057
797 BACK DISORDER 92 0.0057
798 OBESITY 90 0.0056
799 INSOMNIA 1503 0.0056
800 HAEMATOMA 146 0.0056
801 CARDIAC FAILURE CONGESTIVE 452 0.0056
802 HYPOGLYCAEMIA 272 0.0056
803 ARTHRITIS 440 0.0056
804 PELVIC PAIN 101 0.0056
805 MUSCULOSKELETAL PAIN 291 0.0055
806 MEMORY IMPAIRMENT 762 0.0055
807 DIABETIC KETOACIDOSIS 133 0.0055
808 DIABETES MELLITUS 422 0.0055
809 CORONARY ARTERY DISEASE 167 0.0055
810 PRURITUS 2114 0.0055
811 DERMATITIS ALLERGIC 69 0.0055
812 THROAT IRRITATION 246 0.0055
813 ARTHRALGIA 2276 0.0055
814 URTICARIA 917 0.0055
815 DRY EYE 273 0.0055
816 PRODUCT USE COMPLAINT 86 0.0055
817 VISION BLURRED 748 0.0054
818 ALTERED STATE OF CONSCIOUSNESS 118 0.0054
819 HALLUCINATION, VISUAL 115 0.0054
820 MUSCLE ATROPHY 69 0.0054
821 HYPOKINESIA 79 0.0054
822 SWOLLEN TONGUE 169 0.0054
823 ISCHAEMIC STROKE 96 0.0054
824 HYPOAESTHESIA ORAL 81 0.0054
825 CARDIOVASCULAR DISORDER 136 0.0054
826 DEPRESSED MOOD 283 0.0053
827 PRODUCT PRESCRIBING ISSUE 116 0.0053
828 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 137 0.0053
829 ROTATOR CUFF SYNDROME 68 0.0053
830 PULMONARY FIBROSIS 101 0.0053
831 DYSSTASIA 153 0.0052
832 MIDDLE INSOMNIA 97 0.0052
833 MENTAL DISORDER 226 0.0052
834 EYE SWELLING 192 0.0052
835 IMMUNE SYSTEM DISORDER 68 0.0052
836 HERNIA 99 0.0051
837 PSORIASIS 666 0.0051
838 INTERSTITIAL LUNG DISEASE 246 0.0051
839 MUSCULOSKELETAL STIFFNESS 445 0.0051
840 JOINT STIFFNESS 133 0.0051
841 UPPER LIMB FRACTURE 101 0.0051
842 IMPAIRED HEALING 164 0.0050
843 RASH GENERALISED 129 0.0050
844 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 273 0.0050
845 DELUSION 77 0.0050
846 MUSCLE TIGHTNESS 80 0.0049
847 FIBROMYALGIA 120 0.0049
848 AMNESIA 321 0.0049
849 DEAFNESS 129 0.0049
850 ADVERSE DRUG REACTION 440 0.0049
851 BURNING SENSATION 342 0.0049
852 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 877 0.0049
853 NERVOUS SYSTEM DISORDER 151 0.0048
854 BONE DISORDER 88 0.0048
855 TOOTH LOSS 100 0.0048
856 BONE DENSITY DECREASED 151 0.0048
857 HUNGER 67 0.0048
858 PROCEDURAL PAIN 133 0.0048
859 PRODUCT DOSE OMISSION 312 0.0048
860 TREATMENT FAILURE 393 0.0047
861 DERMATITIS 99 0.0047
862 MOBILITY DECREASED 339 0.0047
863 BLOOD CREATINE PHOSPHOKINASE INCREASED 135 0.0047
864 RHABDOMYOLYSIS 195 0.0047
865 WEIGHT INCREASED 1038 0.0046
866 ACCIDENTAL OVERDOSE 169 0.0046
867 SENSORY DISTURBANCE 74 0.0046
868 PANIC ATTACK 168 0.0046
869 TINNITUS 211 0.0046
870 HAEMORRHAGE 480 0.0046
871 EMOTIONAL DISORDER 141 0.0046
872 MULTIPLE FRACTURES 75 0.0046
873 PSYCHOMOTOR HYPERACTIVITY 74 0.0045
874 FEELING ABNORMAL 1063 0.0044
875 NEOPLASM MALIGNANT 293 0.0044
876 VISUAL IMPAIRMENT 543 0.0044
877 CEREBROVASCULAR ACCIDENT 741 0.0044
878 INFLAMMATION 223 0.0043
879 ILL-DEFINED DISORDER 262 0.0043
880 COMPLETED SUICIDE 359 0.0043
881 DRUG ERUPTION 76 0.0043
882 LACTIC ACIDOSIS 138 0.0043
883 IMPAIRED WORK ABILITY 91 0.0043
884 BLOOD GLUCOSE DECREASED 204 0.0042
885 HIP ARTHROPLASTY 65 0.0042
886 CHOKING 82 0.0042
887 COMA 200 0.0042
888 PRODUCT PRESCRIBING ERROR 99 0.0042
889 PRODUCT AVAILABILITY ISSUE 94 0.0041
890 LOWER LIMB FRACTURE 79 0.0041
891 EYE PAIN 231 0.0041
892 DISTURBANCE IN ATTENTION 219 0.0041
893 MOVEMENT DISORDER 129 0.0040
894 EXTRAPYRAMIDAL DISORDER 99 0.0040
895 INCREASED APPETITE 76 0.0040
896 ECZEMA 208 0.0040
897 LOCAL SWELLING 69 0.0040
898 UNEVALUABLE EVENT 294 0.0039
899 PAIN OF SKIN 104 0.0039
900 PRODUCT ADMINISTRATION ERROR 78 0.0039
901 CARDIAC DISORDER 360 0.0038
902 HYPOACUSIS 165 0.0038
903 PRESCRIBED UNDERDOSE 76 0.0038
904 HEPATIC FUNCTION ABNORMAL 142 0.0038
905 LIVER INJURY 93 0.0038
906 EYE PRURITUS 127 0.0038
907 FEELING JITTERY 72 0.0038
908 ROAD TRAFFIC ACCIDENT 157 0.0037
909 DISABILITY 74 0.0037
910 CONVULSION 213 0.0037
911 MYELOSUPPRESSION 134 0.0037
912 PSORIATIC ARTHROPATHY 151 0.0037
913 COLITIS ULCERATIVE 166 0.0037
914 VAGINAL HAEMORRHAGE 161 0.0037
915 EPILEPSY 113 0.0037
916 ABNORMAL BEHAVIOUR 145 0.0037
917 MENTAL IMPAIRMENT 88 0.0036
918 TREATMENT NONCOMPLIANCE 196 0.0036
919 NERVOUSNESS 186 0.0036
920 OVERDOSE 763 0.0035
921 PANCREATIC CARCINOMA 102 0.0035
922 CRYING 127 0.0035
923 ARTHROPATHY 191 0.0034
924 SUICIDAL IDEATION 314 0.0034
925 THERAPEUTIC PRODUCT EFFECT DECREASED 153 0.0034
926 PSYCHOTIC DISORDER 99 0.0033
927 SKIN CANCER 71 0.0033
928 FEMUR FRACTURE 101 0.0033
929 KNEE ARTHROPLASTY 68 0.0032
930 BLINDNESS 130 0.0032
931 MOOD ALTERED 87 0.0032
932 INTENTIONAL OVERDOSE 203 0.0032
933 EYE DISORDER 104 0.0032
934 OCULAR HYPERAEMIA 149 0.0031
935 IRRITABILITY 185 0.0031
936 PRURITUS GENERALISED 66 0.0030
937 OSTEONECROSIS 100 0.0030
938 GASTRIC CANCER 77 0.0030
939 DRUG INEFFECTIVE 3997 0.0030
940 THERAPEUTIC RESPONSE UNEXPECTED 136 0.0030
941 SUICIDE ATTEMPT 179 0.0029
942 OSTEONECROSIS OF JAW 73 0.0029
943 ADVERSE EVENT 269 0.0029
944 FEAR 78 0.0029
945 BLOOD GLUCOSE INCREASED 543 0.0029
946 LUNG NEOPLASM MALIGNANT 118 0.0029
947 MEDICATION ERROR 157 0.0028
948 UNDERDOSE 204 0.0028
949 DEMENTIA 78 0.0028
950 DERMATITIS ATOPIC 146 0.0028
951 SYSTEMIC LUPUS ERYTHEMATOSUS 96 0.0027
952 WITHDRAWAL SYNDROME 113 0.0027
953 TYPE 2 DIABETES MELLITUS 89 0.0026
954 EYE IRRITATION 152 0.0026
955 MOOD SWINGS 84 0.0026
956 DISEASE RECURRENCE 122 0.0026
957 AGGRESSION 128 0.0026
958 MULTIPLE SCLEROSIS RELAPSE 174 0.0025
959 THERAPEUTIC RESPONSE SHORTENED 84 0.0025
960 MYOCARDIAL INFARCTION 430 0.0025
961 ANGER 80 0.0024
962 INJECTION SITE REACTION 162 0.0024
963 INJECTION SITE RASH 71 0.0023
964 THERAPEUTIC RESPONSE DECREASED 140 0.0023
965 DEVICE DISLOCATION 99 0.0023
966 SKIN IRRITATION 102 0.0022
967 ACNE 167 0.0022
968 DRUG DOSE OMISSION 364 0.0022
969 DRUG EFFECT INCOMPLETE 79 0.0022
970 INCORRECT DOSE ADMINISTERED 484 0.0021
971 MULTIPLE SCLEROSIS 98 0.0020
972 INJECTION SITE MASS 75 0.0020
973 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 144 0.0020
974 INJECTION SITE BRUISING 156 0.0020
975 ABORTION SPONTANEOUS 78 0.0019
976 DRUG WITHDRAWAL SYNDROME 169 0.0019
977 INJECTION SITE ERYTHEMA 219 0.0018
978 INJECTION SITE PAIN 512 0.0017
979 BREAST CANCER 154 0.0017
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 115 0.0016
981 INJECTION SITE PRURITUS 107 0.0016
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 319 0.0016
983 INJECTION SITE SWELLING 119 0.0016
984 DEVICE ISSUE 139 0.0015
985 NO ADVERSE EVENT 266 0.0015
986 PRODUCT QUALITY ISSUE 199 0.0015
987 SKIN BURNING SENSATION 104 0.0015
988 DRUG ABUSE 116 0.0014
989 DRUG EFFECT DECREASED 71 0.0013
990 PRODUCT STORAGE ERROR 110 0.0013
991 INJECTION SITE HAEMORRHAGE 100 0.0013
992 DEVICE MALFUNCTION 75 0.0011
993 DRUG DEPENDENCE 155 0.0010
994 ACCIDENTAL EXPOSURE TO PRODUCT 93 0.0009